CHMP2B and Alzheimer disease: AD patient brain tissue also exhibited intra-neuronal and global elevation of Aβ, CHMP2B and Galectin-3 immunoreactivity colocalized with LAMP2, compared with healthy control (HC) individuals (Fig. 4c, and Extended Data Fig. 10a–d).